It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Brown adipose tissue expresses uncoupling protein 1 (UCP1), which dissipates energy as heat, making it a target for treating metabolic disorders. Here, we investigate how purine nucleotides inhibit respiration uncoupling by UCP1. Our molecular simulations predict that GDP and GTP bind UCP1 in the common substrate binding site in an upright orientation, where the base moiety interacts with conserved residues R92 and E191. We identify a triplet of uncharged residues, F88/I187/W281, forming hydrophobic contacts with nucleotides. In yeast spheroplast respiration assays, both I187A and W281A mutants increase the fatty acid-induced uncoupling activity of UCP1 and partially suppress the inhibition of UCP1 activity by nucleotides. The F88A/I187A/W281A triple mutant is overactivated by fatty acids even at high concentrations of purine nucleotides. In simulations, E191 and W281 interact with purine but not pyrimidine bases. These results provide a molecular understanding of the selective inhibition of UCP1 by purine nucleotides.
Combining molecular dynamic simulations with in vivo functional assays, Gagelin et al. identified unique molecular features of the mitochondrial carrier uncoupling protein 1 that are crucial to its inhibition by nucleotides
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Miroux, Bruno 3
1 Université Paris Cité, Laboratoire de Biochimie Théorique CNRS UPR9080, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602); Institut de Biologie Physico-Chimique, Fondation Edmond de Rothschild, Paris, France (GRID:grid.450875.b) (ISNI:0000 0004 0643 538X)
2 Université Paris Cité, Laboratoire de Biochimie Théorique CNRS UPR9080, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602); Institut de Biologie Physico-Chimique, Fondation Edmond de Rothschild, Paris, France (GRID:grid.450875.b) (ISNI:0000 0004 0643 538X); Université Paris Cité, Laboratoire de Biologie Physico-Chimique des Protéines Membranaires CNRS UMR7099, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
3 Institut de Biologie Physico-Chimique, Fondation Edmond de Rothschild, Paris, France (GRID:grid.450875.b) (ISNI:0000 0004 0643 538X); Université Paris Cité, Laboratoire de Biologie Physico-Chimique des Protéines Membranaires CNRS UMR7099, Paris, France (GRID:grid.508487.6) (ISNI:0000 0004 7885 7602)
4 Université Paris Cité, Institut Cochin, Inserm U1016, CNRS UMR8104, Paris, France (GRID:grid.462098.1) (ISNI:0000 0004 0643 431X)




